Dr. Soheir S. Adam, MD

Dr. Adam practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Adam's NPI, 1366690711, was assigned on August 28, 2008. Dr. Adam graduated from Cairo University School of Medicine in 1984. Dr. Adam's North Carolina license number on file is 200801390.

Dr. Adam's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Adam's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Adam to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adam practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Adam's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Adam has a license on file in North Carolina.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT) and purpura and thrombocytopenia among the conditions Dr. Adam treats.

CMS data shows 160 Medicare services from Dr. Adam across 6 procedure codes in 2024, for 85 Medicare patients. Medicare paid $10,704 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Adam in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adam's median patient age at 67, with 64% women.

In 2024, Dr. Adam wrote 101 Medicare Part D claims for 31 patients. 35% of them were for generic drugs. CMS names the drug for 88 of them, across 2 drugs with 11 or more claims each, at $43,541 in total drug cost. In 2023, CMS named 136 claims across 5 drugs.

Dr. Adam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Adam, published from 2008 to 2023. 2020 was the busiest year, with 6. The most frequent topics are Venous Thromboembolism, Anemia, Sickle Cell and Hemorrhage. Dr. Adam has published most often in Thromb Res. Dr. Adam's most frequent co-authors are Thomas Lee Ortel, MD, Nigel S. Key, MD and Varun Samji.

CMS Open Payments shows 6 general payments to Dr. Adam from 2 drug and device companies from 2019 to 2022. Travel and lodging make up the largest share, 76% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,505. It also lists 2 research payments totaling $692 in 2022.

Dmand AI lists 1 award for Dr. Adam, most recently CMS Stage 1 EHR in 2013.

Dr. Adam graduated from Cairo University School of Medicine in 1984.

Dr. Adam is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.